DanielJLovellMD

PubMed

• 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyar...
  Sarah Ringold, Sheila T Angeles-Han, Timothy Beukelman, Daniel Lovell, Carlos A Cuello
  Arthritis Care & Research. 2019-06-01
• 254 citations
  Toward New Classification Criteria for Juvenile Idiopathic Arthritis : First Steps, Pediatric Rheumatology International Trials Organization International Consensus
  Alberto Martini, Angelo Ravelli, Tadej Avcin, Michael W. Beresford, Ruben Burgos-Vargas
  The Journal of Rheumatology. 2019-02-01
• 111 citations
  Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study.
  Alessandro Consolaro, Gabriella Giancane, Alessandra Alongi, Evert Hendrik Pieter van Dijkhuizen, Amita Aggarwal
  The Lancet. Child & Adolescent Health. 2019-04-01

Journal Articles

• Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016  
  Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
• Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial  
  Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rocket..., Arthritis Rheum, 2/1/2013
• American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis  
  Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N; Childhood Arthritis Rheumatology Research Alliance; Pediatric Rheumatology Collaborative Study Group; Paediatric ..., Arthritis Care Res, 7/1/2011
• International Flare Consensus Initiative International consensus for a definition of disease flare in lupus  
  Ruperto N, Hanrahan LM, Alarcón GS, Belmont HM, Brey RL, Brunetta P, Buyon JP, Costner MI, Cronin ME, Dooley MA, Filocamo G, Fiorentino D, Fortin PR, Franks AG Jr, Gil..., Lupus, 4/1/2011
• Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort  
  Ardoin SP, Schanberg LE, Sandborg C, Yow E, Barnhart HX, Mieszkalski Kl, Ilowite NT, von Scheven E, Eberhard A, Levy DM, Kimura Y, Silverman E, Bowyer SL, Punaro L, Si..., Lupus, 10/1/2010
• The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis  
  Ruperto N, Pistorio A, Ravelli A, Rider LG, Pilkington C, Oliveira S, Wulffraat N, Espada G, Garay S, Cuttica R, Hofer M, Quartier P, Melo-Gomes J, Reed AM, Wierzbowsk..., Arthritis Care Res, 6/1/2010
• Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis  
  Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, Cintas HL, McGarvey CL, James-Newton L, Pokrovnichka A, Moini B, Cabalar I, Lovell DJ, Wesley R, Pl..., Rheumatology, 2/1/2009
• Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: an American College of Rheumatology white paper  
  American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs, Arthritis Rheum, 8/1/2008
• Intra-rater and inter-rater reliability of the 10-point Manual Muscle Test (MMT) of strength in children with juvenile idiopathic inflammatory myopathies (JIIM)  
  Jain M, Smith M, Cintas H, Koziol D, Wesley R, Harris-Love M, Lovell D, Rider LG, Hicks J, Phys Occup Ther Pediatr, 1/1/2006
• Use of etanercept in children  
  Wargula JC, Lovell DJ, Bull Rheum Dis, 1/1/2000
• Ten years of experience with methotrexate Past, present and future  
  Lovell DJ, Rev Rhum Engl Ed, 10/15/1997
• Outcome in pediatric rheumatic disease  
  Graham TB, Lovell DJ, Curr Opin Rheumatol, 9/1/1997
• Recognition of infantile-onset multisystem inflammatory disease as a unique entity  
  Hashkes PJ, Lovell DJ, J Pediatr, 4/1/1997
• Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy  
  Hashkes PJ, Lovell DJ, Clin Exp Rheumatol, 11/1/1996
• Long term follow-up of children with mixed connective tissue disease  
  Mier R, Ansell B, Hall MA, Hasson N, Levinson J, Lovell D, Passo M, Rennebohm R, Woo P, Lupus, 6/1/1996
• Chlamydial associated syndrome of arthritis and eye involvement in young children  
  Maximov AA, Shaikov AV, Lovell DJ, Giannini EH, Soldatova SI, JRheumatol, 11/1/1992
• A nutritional screening test for use in children and adolescents with juvenile rheumatoid arthritis  
  Henderson CJ, Lovell DJ, Gregg DJ, J Rheumatol, 8/1/1992
• Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--...  
  Shaikov AV, Maximov AA, Speransky AI, Lovell DJ, Giannini EH, Solovyev SK, J Rheumatol, 4/1/1992
• Nutritional aspects of juvenile rheumatoid arthritis  
  Henderson CJ, Lovell DJ, Rheum Dis Clin North Am, 5/1/1991
• Nutritional aspects of juvenile rheumatoid arthritis  
  Henderson CJ, Lovell DJ, Rheumatic Dis Clinics of North America, 1/1/1991
• Pain associated with Juvenile Rheumatoid Arthritis  
  Lovell DJ, Walco GA, Pediatric Clinics of North America, 1/1/1989
• Infantile-onset multisystem inflammatory disease:radiologic findings  
  Kaufman RA, Lovell DJ, Radiology, 9/1/1986
• Join now to see all

Books/Book Chapters

• Manual Practico de Rheumatologia Pediatrica 
  Chapter: Therpia biologica en las enfermedades reumaticias en pediatria 
  Smith JA, Carrasco R, Lovell DJNobuko, Buenos Aires, Argentina2006
• Textbook of Pediatric Rheumatology 
  Chapter: Assessment of health status, function and outcome 
  Duffy C, Lovell DJEditors: Cassidy K and Petty R.WB Saunders, Philadelphia, PAEdition 4th,2001
• Nelson Textbook of Pediatrics 
  Chapter: Treatment of rheumatic diseases 
  Lovell DJ, Miller ML, Cassidy JTWB Saunders, Philadelphia, PAEdition 16th,1999
• Primer on the Rheumatic Diseases 
  Chapter: Juvenile rheumatoid arthritis and juvenile spondyloarthropathies 
  Page 393 - 398Lovell DJArthritis Foundation PressEdition 11th,1996
• Pediatric Nutrition in Chronic and Developmental Disorders. Prevention, Assessment and Treatment 
  Chapter: Juvenile Rheumatoid Arthritis 
  Page 263 - 268Lovell DJ, Henderson CJEditors: Ekvall S.Oxford University Press, Inc.1993
• Textbook of Pediatric Nutrition 
  Chapter: Nutritional considerations in the diagnosis and treatment of children with juvenile arthritis 
  Page 407 - 415Lovell DJEditors: Suskind RM.Raven Press, New York, NYEdition 2nd,1993
• Oxford Textbook of Rheumatology 
  Chapter: Growth and Skeletal Maturation 
  Page 481 - 496Lovell DJEditors: Maddison P, Isenberg D, Woo P, Glass D.Oxford University Press, Oxford, England1993
• Balliere's Clin Pediatr 
  Chapter: Clinical and functional monitoring, Outcome Measures, and Prognosis of Arthritis 
  Page 769 - 801Lovell DJ, De Inocencio J1993
• Bailliere's Clin Paed 
  Chapter: Clinical and functional monitoring, outcome measures and prognosis of juvenile chronic arthritis 
  Page 769 - 801De Inocencio J, Lovell DJ1993
• Bailliere's Clin Paed 
  Chapter: Complications associated with juvenile chronic arthritis 
  Page 897 - 918Malleson PN, De Inocencio J, Lovell, DJ1993
• Pediatric Rheumatology Update 
  Chapter: Growth and Nutrition in Juvenile Rheumatoid Arthritis 
  Page 47 - 56Lovell DJ, White PHEditors: Woo P, White P, Ansell B.Oxford University Press, Oxford, England1989
• Pediatric Rheumatology Update 
  Chapter: The chronic, infantile, neurological, cutaneous and articular syndrome CINCA 
  Page 147 - 160Prieur AM, Lovell DJEditors: Woo P, White P, Ansell B.Oxford University Press, Oxford, England1989
• Join now to see all

Abstracts/Posters

• The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritis
  Giannini EH, Ilowite NT, Lovell DJ, et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis (JIA): Results of double-blind withdrawal phase
  Block AJ, Ruperto N, Lovell DJ, Giannini EH, Martini A, Rheumatology, 1/1/2007
• The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritis
  Giannini EH, Ilowite NT, Lovell DJ, et al, Annals of Rheumatic Diseases, 1/1/2007
• Safety of over 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
  Lovell DJ, Giannini EH, Wallace CA et al, Annals of Rheumatic Diseases, 1/1/2007
• Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): Data over two years of treatment in a phase III trial
  Ruperto N, Lovell DJ, Goodman S, Reiff..Martini A, Giannini EH, Annals of Rheumatic Diseases, 1/1/2007
• Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): Converting from body surface area dosing to fixed dosing in the open-...
  Ruperto N, Lovell DJ, Goodman S, Reiff A.Martini A, Giannini EH, Annals of Rheumatic Diseases, 1/1/2007
• Re-establishment of clinical benefit in patients with juvenile idiopathic arthritis after abatacept withdrawal and subsequent re-introduction
  Ruperto N, Giannini EH, Quartier P, et al, Annals of Rheumatic Diseases, 1/1/2007
• Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis: Results of double-blind withdrawal phase
  Ruperto N, Giannini EH, Prieur A-M et al, Annals of Rheumatic Diseases, 1/1/2007
• Two-year efficacy of adalimumab in children with juvenile rheumatoid arthritis (JRA): Results of a Phase III trial
  Ruperto N, Lovell DJ,…Giannini EH, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Efficacy and safety of abatacept in children and adolescents with active juvenile idiopathic arthritis: Results of double-blind withdrawal phase
  Ruperto N, Giannini EH, Prieur A-M et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Preliminary evidence for sustained bioactivity of IL-1 Trap (Rilonocept), a long acting IL-1 inhibitor in systemic juvenile rheumatoid arthritis
  Lovell DJ, Giannini EH, et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Re-establishment of clinical benefit in patients with juvenile idiopathic arthritis after abatacept withdrawal and subsequent re-introduction
  Ruperto N, Giannini EH, Quartier P, et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• A new multicenter registry to monitor long-term safety of non-steroidal anti-inflammatory drugs (NSAIDs) including Celebrex in juvenile idiopathic arthritis (JIA)
  Sobel RE, Lovell, DJ, Giannini EH, Sheth N, Abramsky S, Cawkwell G, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Safety and efficacy of over 8 years of continuous etanercept (Enbrel) therapy in patients with juvenile rheumatoid arthritis
  Lovell DJ, Giannini EH, Wallace CA, et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Long-term efficacy and safety of adalimumab in children with juvenile rheumatoid arthritis (JRA): Converting from body surface area dosing to fixed dosing
  Ruperto N, Lovell DJ…Giannini EH, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Efficacy of abatacept in different sub-populations of juvenile idiopathic arthritis. Results from a double-blind trial
  Giannini EH, Ruperto N, Prieur A-M et al, Proceeding of the 14th Pediatric Rheumatology European Society Rheumatology Congress, 1/1/2007
• Abatacept treatment of juvenile idiopathic arthritis: safety report
  Lovell DJ, ….Giannini EH, Martini A, Arthritis & Rheum, 1/1/2007
• Adalimumab is safe and effective during long-term treatment of patients with juvenile rheumatoid arthritis. Results from a 2 year study
  Lovell DJ…Giannini EH, Martini A, Arthritis & Rheum, 1/1/2007
• Safety and Efficacy of over 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
  Reiff AO, Giannini EH, Arthritis & Rheum, 1/1/2007
• Adalimumab for the treatment of patients with juvenile rheumatoid arthritis: safety and efficacy after conversion from body-surface-area dosing to weight-based fixed d...
  Lovell DJ…Giannini EH, Martini A, Arthritis & Rheum, 1/1/2007
• Clinical trial safety data of events of interest in patients receiving etanercept across approved indications
  Gordon KB, Gottlieb AB, Giannini EH et al, Arthritis & Rheum, 1/1/2007
• Preliminary evidence for sustained bioactivity of IL-1 Trap (Rilonocept), a long acting IL-1 inhibitor in systemic juvenile rheumatoid arthritis
  Lovell DJ, Giannini EH, et al, Arthritis & Rheum, 1/1/2007
• Development of a provisional core set of response measures for clinical trials of systemic sclerosis
  Khana D, Lovell DJ, Giannini EH et al, Arthritis & Rheum, 1/1/2007
• Preliminary evidence for bioactivity of IL-1 Trap (Rilonacept), A long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis
  Lovell DJ, Giannini EH, Kimura Y, …Radin A, Annals of Rheumatic Diseases, 1/1/2006
• Efficacy and safety of abatacept in children in and adolescents with active juvenile idiopathic arthritis (JRA)
  Ruperto N, Lovell DJ, Prieur A-M…Giannini EH, Annals of Rheumatic Diseases, 1/1/2006
• Join now to see all

Other

• What are growing pains, anyway? 
  Lovell DJ, McCall's
  5/1/1996